Results 211 to 220 of about 3,393,912 (377)

C-reactive protein is produced by a small number of normal human peripheral blood lymphocytes. [PDF]

, 1986
Alexander E. Kuta, Linda L. Baum
openalex   +1 more source

Evaluation and modification of tumor cell isolation techniques from malignant effusions for rapid drug sensitivity testing

Molecular Oncology, EarlyView.
Non‐small cell lung cancer targeted treatment is limited to a few known genetic alterations, with few alternatives in advanced treatment lines. To direct treatment decisions by drug sensitivity testing (DST), this study compared several methods for tumor cell isolation from malignant effusions, pointing to repeated CD45+ cell depletion for effective ...
Navit Mooshayef, Hana Barhom, Sumit Chatterji, Netta Hecht, Oran Warhaftig, Iris Kamer, Oranit Zadok, Jair Bar, Limor Broday, Amir Onn, Michael Peled   +10 more
wiley   +1 more source

C-reactive protein: the nexus between inflammation and protein misfolding diseases. [PDF]

Front Immunol
Roy A, Zeller J, Nero TL, Klepetko J, Eisenhardt SU, Parker MW, McFadyen JD, Peter K.   +7 more
europepmc   +1 more source

High Sensitive C-Reactive Protein (hs-CRP) and Its Correlation with Angiographic Severity of Patient with Coronary Artery Disease (CAD)

, 1970
MA Hasnat, AEMM Islam, AW Chowdhury, HILR Khan, MZ Hossain   +4 more
openalex   +2 more sources

Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models

Molecular Oncology, EarlyView.
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon, Moa Stenudd, Margherita Zamboni, Kanar Alkass, Carl‐Johan Eriksson, Lars Pedersen, Alrik Schörling, Anna Thoss, Anders Bergh, Pernilla Wikström, Hans‐Olov Adami, Henrik Toft Sørensen, Henrik Druid, Jonas Frisén   +13 more
wiley   +1 more source

The relationship between C-reactive protein-albumin-lymphocyte index and peripheral artery disease. [PDF]

Sci Rep
Wu Z, Fu L, Liu X, Gong C, Wu Q, Li W, Wang B.   +6 more
europepmc   +1 more source

Usefulness of CSF C-Reactive Protein in Differentiating Pyogenic and Aseptic Meningitis

, 1970
Md Belal Uddin, Manjira Rahman, AB Siddique   +2 more
openalex   +2 more sources

Serum beta 2 microglobulin and C-reactive protein in the monitoring of lymphomas findings in a multicenter study and experience in selected patients [PDF]

, 1980
J. A. Child, B Späti, Sarah Illingworth, D. L. Barnard, Sheila Corbett, A. V. Simmons, Joan Stone, T. S. Worthy, E.H. Cooper   +8 more
openalex   +1 more source

Endoglin mediates the tumor‐ and metastasis‐promoting traits of stromal myofibroblasts in human breast carcinomas

Molecular Oncology, EarlyView.
Carcinoma‐associated fibroblasts (CAFs) in tumors influence cancer progression. We identified endoglin (ENG) as a key factor in TGF‐β signaling in myofibroblastic CAFs (myCAFs), linked to poor breast cancer outcomes. Inhibiting ENG on myCAFs suppressed the TGF‐β‐Smad2/3 pathway, reducing primary tumor growth and metastasis.
Shoki Okubo, Yoshihiro Mezawa, Zixu Wang, Ahmet Acar, Yasuhiko Ito, Atsushi Takano, Yohei Miyagi, Tomoyuki Yokose, Toshinari Yamashita, Yataro Daigo, Takuya Shirakihara, Akira Orimo   +11 more
wiley   +1 more source

Prognostic value of the C-reactive protein to albumin ratio in patients with stroke: a meta-analysis. [PDF]

Sci Rep
Yang J, Chen Y, Wan J, Li F, Yang X, Shen B, Li N, Didi J, Zhou L, Zhang Y.   +9 more
europepmc   +1 more source